Fetoplacental disturbances in gestational diabetes mellitus;Fetoplazentare Störungen bei Gestationsdiabetes

Gynakologisch-geburtshilfliche Rundschau

Volumn 49, Issue 4, 2009, Pages 224-229

  Hiden, Ursula ^a   Lang, Uwe ^a   Desoye, Gernot ^a  

^a UNIV KLIN FÜR FRAUENHEILKUNDE   (Austria)

Author keywords

Gestational diabetes mellitus; Insulin; Insulin like growth factor; Placenta; Types 1 and 2

Indexed keywords

CYTOKINE; GROWTH FACTOR; HORMONE; INSULIN; INSULIN RECEPTOR; SOMATOMEDIN B; SOMATOMEDIN C;

FETOPLACENTAL UNIT; FETUS; FETUS CIRCULATION; FETUS DEVELOPMENT; FETUS GROWTH; HUMAN; PLACENTA DEVELOPMENT; PREGNANCY DIABETES MELLITUS; PROTEIN BLOOD LEVEL; REVIEW;

BIRTH WEIGHT; DIABETES, GESTATIONAL; FEMALE; HUMANS; INFANT, NEWBORN; INSULIN; INSULIN-LIKE GROWTH FACTOR II; MATERNAL-FETAL EXCHANGE; PLACENTAL CIRCULATION; PREGNANCY;

EID: 77953209565     PISSN: 10188843     EISSN: None     Source Type: Journal    
DOI: 10.1159/000301073     Document Type: Review

References (65)

1. Fee BA, Weil WB Jr: Body composition of infants of diabetic mothers by direct analysis. Ann NY Acad Sci 1963; 110: 869-897.
2. Durnwald C, et al: Evaluation of body composition of large-for- gestational-age infants of women with gestational diabetes mellitus compared with women with normal glucose tolerance levels. Am J Obstet Gynecol 2004; 191: 804-808.
3. Desoye G, Hofmann HH, Weiss PA: Insulin binding to trophoblast plasma membranes and placental glycogen content in well-controlled gestational diabetic women treated with diet or insulin, in well-controlled overt diabetic patients and in healthy control subjects. Diabetologia 1992; 35: 45-55.
4. Osmond DT, et al: Placental glucose transport and utilisation is altered at term in insulin- treated, gestational-diabetic patients. Diabetologia 2001; 44: 1133-1139.
5. Osmond DT, et al: Effects of gestational diabetes on human placental glucose uptake, transfer, and utilisation. Diabetologia 2000; 43: 576-582.
6. Jansson T, et al: Alterations in the activity of placental amino acid transporters in pregnancies complicated by diabetes. Diabetes 2002; 51: 2214-2219.
7. Dicke JM, Henderson GI: Placental amino acid uptake in normal and complicated pregnancies. Am J Med Sci 1988; 295: 223-227.
8. Kuruvilla AG, et al: Altered activity of the system A amino acid transporter in microvillous membrane vesicles from placentas of macrosomic babies born to diabetic women. J Clin Invest 1994; 94: 689-695.
9. Thomas B, et al: Plasma AA and DHA levels are not compromised in newly diagnosed gestational diabetic women. Eur J Clin Nutr 2004; 58: 1492-1497.
10. Ortega-Senovilla H, et al: Gestational diabetes mellitus upsets the proportion of fatty acids in umbilical arterial but not venous plasma. Diabetes Care 2009; 32: 120-122.
11. Bitsanis D, et al: Gestational diabetes mellitus enhances arachidonic and docosahexaenoic acids in placental phospholipids. Lipids 2006; 41: 341-346.
12. Merzouk H, et al: Changes in serum lipid and lipoprotein concentrations and compositions at birth and after 1 month of life in macrosomic infants of insulin-dependent diabetic mothers. Eur J Pediatr 1999; 158: 750-756.
13. Couch SC, et al: Elevated lipoprotein lipids and gestational hormones in women with diet-treated gestational diabetes mellitus compared to healthy pregnant controls. J Diabetes Complications 1998; 12: 1-9.
14. al-Okail MS, al-Attas OS: Histological changes in placental syncytiotrophoblasts of poorly controlled gestational diabetic patients. Endocr J 1994; 41: 355-360.
15. Leushner JR, et al: Analysis of the collagens of diabetic placental villi. Cell Mol Biol 1986; 32: 27-35.
16. Madsen H, Ditzel J: Red cell 2,3-diphosphoglycerate and hemoglobin-oxygen affinity during diabetic pregnancy. Acta Obstet Gynecol Scand 1984; 63: 403-406. (Pubitemid 14040429)
17. Madazli R, et al: The incidence of placental abnormalities, maternal and cord plasma malondialdehyde and vascular endothelial growth factor levels in women with gestational diabetes mellitus and nondiabetic controls. Gynecol Obstet Invest 2008; 65: 227-232.
18. Mayhew TM, et al: Growth and maturation of villi in placentae from well-controlled diabetic women. Placenta 1994; 15: 57-65.
19. Black SM, Devol JM, Wedgwood S: Regulation of fibroblast growth factor-2 expression in pulmonary arterial smooth muscle cells involves increased reactive oxygen species generation. Am J Physiol Cell Physiol 2008; 294:C345-C354.
20. Josko J, Mazurek M: Transcription factors having impact on vascular endothelial growth factor (VEGF) gene expression in angiogenesis. Med Sci Monit 2004; 10:RA89- RA98.
21. Jirkovska M, et al: Topological properties and spatial organization of villous capillaries in normal and diabetic placentas. J Vasc Res 2002; 39: 268-278.
22. Iioka H, et al: Nonenzymatic glucosylation of human placental trophoblast basement membrane collagen (relation to diabetic placenta pathology) (auf Japanisch). Nippon Sanka Fujinka Gakkai Zasshi 1987; 39: 400-404.
23. Hauguel-de Mouzon S, Louizeau M, Girard J: Functional alterations of type I insulinlike growth factor receptor in placenta of diabetic rats. Biochem J 1992; 288: 273-279.
24. +-ATPase activity and expression in syncytiotrophoblast plasma membranes in pregnancies complicated by diabetes. Placenta 2002; 23: 386-391.
25. Gaither K, Quraishi AN, Illsley NP: Diabetes alters the expression and activity of the human placental GLUT1 glucose transporter. J Clin Endocrinol Metab 1999; 84: 695-701.
26. Schonfelder G, et al: Expression of inducible nitric oxide synthase in placenta of women with gestational diabetes. FASEB J 1996; 10: 777-784.
27. Lea RG, et al: Placental leptin in normal, diabetic and fetal growth-retarded pregnancies. Mol Hum Reprod 2000; 6: 763-769.
28. Burleigh DW, et al: Influence of maternal diabetes on placental fibroblast growth factor-2 expression, proliferation, and apoptosis. J Soc Gynecol Investig 2004; 11: 36-41.
29. Yang WC, et al: Altered perlecan expression in placental development and gestational diabetes mellitus. Placenta 2005; 26: 780-788.
30. Babawale MO, et al: Effects of gestational diabetes on junctional adhesion molecules in human term placental vasculature. Diabetologia 2000; 43: 1185-1196.
31. Magnusson AL, et al: Triglyceride hydrolase activities and expression of fatty acid binding proteins in the human placenta in pregnancies complicated by intrauterine growth restriction and diabetes. J Clin Endocrinol Metab 2004; 89: 4607-4614.
32. Alonso A, et al: Effects of gestational diabetes mellitus on proteins implicated in insulin signaling in human placenta. Gynecol Endocrinol 2006; 22: 526-535.
33. Bhaumick B, Danilkewich AD, Bala RM: Altered placental insulin and insulin-like growth factor-I receptors in diabetes. Life Sci 1988; 42: 1603-1614.
34. Radaelli T, et al: Gestational diabetes induces placental genes for chronic stress and inflammatory pathways. Diabetes 2003; 52: 2951-2958.
35. Gicquel C, Le Bouc Y: Hormonal regulation of fetal growth. Horm Res 2006; 65(suppl 3):28-33.
36. Desoye G, et al: Location of insulin receptors in the placenta and its progenitor tissues. Microsc Res Tech 1997; 38: 63-75.
37. Hiden U, et al: Insulin control of placental gene expression shifts from mother to foetus over the course of pregnancy. Diabetologia 2006; 49: 123-131.
38. Susa JB, et al: Chronic hyperinsulinemia in the fetal rhesus monkey: effects of physiologic hyperinsulinemia on fetal growth and composition. Diabetes 1984; 33: 656-660.
39. Godfrey KM, et al: Relation of cord plasma concentrations of proinsulin, 32-33 split proinsulin, insulin and C-peptide to placental weight and the baby's size and proportions at birth. Early Hum Dev 1996; 46: 129-140.
40. Shields BM, et al: Mutations in the glucokinase gene of the fetus result in reduced placental weight. Diabetes Care 2008; 31: 753-757.
41. Lemons JA, Ridenour R, Orsini EN: Congenital absence of the pancreas and intrauterine growth retardation. Pediatrics 1979; 64: 255-257.
42. Kaufmann P, Luckhardt M, Leiser R: Threedimensional representation of the fetal vessel system in the human placenta. Trophoblast Res 1988; 3: 113-117.
43. Mayhew TM: Fetoplacental angiogenesis during gestation is biphasic, longitudinal and occurs by proliferation and remodelling of vascular endothelial cells. Placenta 2002; 23: 742-750.
44. Hiden U, et al: Insulin and the IGF system in the human placenta of normal and diabetic pregnancies. J Anat 2009; 215: 60-68.
45. Westgate JA, et al: Hyperinsulinemia in cord blood in mothers with type 2 diabetes and gestational diabetes mellitus in New Zealand. Diabetes Care 2006; 29: 1345-1350.
46. Treins C, et al: Insulin stimulates hypoxiainducible factor 1 through a phosphatidylinositol 3-kinase/target of rapamycin-dependent signaling pathway. J Biol Chem 2002; 277: 27975-27981.
47. Lang I, et al: Human fetal placental endothelial cells have a mature arterial and a juvenile venous phenotype with adipogenic and osteogenic differentiation potential. Differentiation 2008; 76: 1031-1043.
48. Lucas J, et al: The effect of fetal hyperinsulinemia on human placental vascular function: perfusion of fetal microvascular bed with high insulin results in increased vascular leakage and loss of junctional betacatenin. Microcirculation, im Druck.
49. Leach L, et al: Vascular endothelial cadherin and beta-catenin in human fetoplacental vessels of pregnancies complicated by type 1 diabetes: associations with angiogenesis and perturbed barrier function. Diabetologia 2004; 47: 695-709.
50. Schmon B, et al: Insulin and glucose do not affect the glycogen content in isolated and cultured trophoblast cells of human term placenta. J Clin Endocrinol Metab 1991; 73: 888-893.
51. Desoye G, Hauguel-de Mouzon S: The human placenta in gestational diabetes mellitus: the insulin and cytokine network. Diabetes Care 2007; 30(suppl 2):S120-S126.
52. Jones CJ, Desoye G: Glycogen distribution in the capillaries of the placental villus in normal, overt and gestational diabetic pregnancy. Placenta 1993; 14: 505-517.
53. Hayati AR, et al: Insulin-like growth factor-1 receptor expression in the placentae of diabetic and normal pregnancies. Early Hum Dev 2007; 83: 41-46.
54. Guyda HJ: Metabolic effects of growth factors and polycyclic aromatic hydrocarbons on cultured human placental cells of early and late gestation. J Clin Endocrinol Metab 1991; 72: 718-723.
55. Karl PI: Insulin-like growth factor-1 stimulates amino acid uptake by the cultured human placental trophoblast. J Cell Physiol 1995; 165: 83-88.
56. Bloxam DL, Bax BE, Bax CM: Epidermal growth factor and insulin-like growth factor I differently influence the directional accumulation and transfer of 2-aminoisobutyrate (AIB) by human placental trophoblast in two-sided culture. Biochem Biophys Res Commun 1994; 199: 922-929.
57. Cetin I, et al: Maternal and fetal amino acid concentrations in normal pregnancies and in pregnancies with gestational diabetes mellitus. Am J Obstet Gynecol 2005; 192: 610-617.
58. Abuzzahab MJ, et al: IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation. N Engl J Med 2003; 349: 2211-2222.
59. Okubo Y, et al: Cell proliferation activities on skin fibroblasts from a short child with absence of one copy of the type 1 insulin-like growth factor receptor (IGF1R) gene and a tall child with three copies of the IGF1R gene. J Clin Endocrinol Metab 2003; 88: 5981-5988.
60. Takayama S, et al: Reproductive toxicity of ofloxacin. Arzneimittelforschung 1986; 36: 1244-1248.
61. Shapiro LR, et al: The placenta in familial Beckwith-Wiedemann syndrome. Birth Defects Orig Artic Ser 1982; 18: 203-206.
62. Hughes SC, et al: Could abnormalities in insulin- like growth factors and their binding proteins during pregnancy result in gestational diabetes? J Endocrinol 1995; 147: 517-524.
63. Gelato MC, et al: The serum insulin-like growth factor-II/mannose-6- phosphate receptor in normal and diabetic pregnancy. Metabolism 1993; 42: 1031-1038.
64. Lindsay RS, et al: Inverse changes in fetal insulin- like growth factor (IGF)-1 and IGF binding protein-1 in association with higher birth weight in maternal diabetes. Clin Endocrinol (Oxf) 2007; 66: 322-328.
65. Roth S, et al: Insulin-like growth factors I and II peptide and messenger RNA levels in macrosomic infants of diabetic pregnancies. J Soc Gynecol Investig 1996; 3: 78-84.